Skip to content

OPTIMIZATION of ADVANCED MR SEQUENCES

OPTIMIZATION of AVANCED MR SEQUENCES for BRAIN STUDIES in VOLUNTEERS (HEALTHY and PATIENTS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05618990
Acronym
OPT-IRM
Enrollment
300
Registered
2022-11-16
Start date
2019-11-05
Completion date
2025-12-05
Last updated
2024-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor, Mental Disorders, MRI, Neurosciences, Stroke

Brief summary

This monocentric methodological study aims at optimizing advanced MR sequences for image quality (reduced artefacts, signal to noise ratio, acquisition time, stability of quantitative measurements) on a new MR unit dedicated to research in clinical and cognitive neuroscience.

Detailed description

Primary goal : Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Secondary goals 1. Perform acquisitions to validate the feasibility of research MR protocols (pilot subjects) 2. reproducibility studies

Interventions

None listed

Sponsors

Centre Hospitalier St Anne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 ans * Covered by social security * For women in age of procreation, under efficient contraception * Written consent

Exclusion criteria

* Any MR contraindication * Claustrophobia * Pregnancy * Under judiciary protection

Design outcomes

Primary

MeasureTime frameDescription
MR sequences optimization72 monthsOptimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Outcome measures depend on each pulse optimized sequence (signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).

Secondary

MeasureTime frameDescription
Reproducibility studies72 monthsReproducibility studies (quantitative parameters, effect of denoising ...). Outcome measures depend on each pulse optimized sequence (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).
Pilot studies72 monthsFeasibility studies in cognitive neurosciences. Outcome measures depend on each MR protocol (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).

Countries

France

Contacts

Primary ContactKhaoussou SYLLA
k.sylla@ghu-paris.fr01 45 65 76 78
Backup ContactViviane AWASSI
v.awassi@ghu-paris.fr01 45 65 84 86

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026